Duloxetine in the prevention of relapse of major depressive disorder: double-blind placebo-controlled study Perahia DG, Gilaberte I, Wang F, Wiltse CG, Huckins SA, Clemens JW, Montgomery SA, Montejo AL, Detke MJ. British Journal of Psychiatry 188:346-53. FI: 5.777 (Q1) Calidad de vida y funcionamiento social en pacientes con esquizofrenia en monoterapia con Olanzapina. Estudio naturalístico de un año de seguimiento Mayoral F, Montejo AL, Bousoño M, González-Torres MA, Olivares JM, Ros S, Sanjuán J, Escobar R, Lara N. Actas Españolas de Psiquiatria 34(1):7-15. FI: 0.515 (Q4) Subjective perception of cognitive deficit in psychotic patients Sanjuán J, Aguilar EJ, Olivares JM, Ros S, Montejo AL, Mayoral F, Gonzalez-Torres MA, Bousoño M. Journal of Nervous and Mental Disease 194(1):58-60. FI: 1.771 (Q3) Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with Ziprasidone in clinical practice settings: a 3-month, prospective, observational study Montejo AL, Rico-Villademoros F, Daniel E, Derecho J, Franch J, Franco M , Gallego MT , Goenaga E, Gómez F, Iglesias C, Holm OM, Prieto N , Romero V, Ros S, Rubio I, Sánchez M. Journal of Clinical Psychopharmacology 28(5):568-70. FI: 5.092 (Q1) Psychometric properties of the Psychotropic-Related sexual dysfunction questionnaire (prsexdq-SALSEX) in patients with schizophrenia and other psychotic disorders Montejo AL, Rico-Villademoros F. J SEX & Marital Therapy 34(3):227-239. FI: 2.260 (Q1) Prolactin awareness: an essential consideration for physical health in schizophrenia Montejo AL. European Neuropsychopharmacology 18(supl 2):101-130. FI: 3.684 (Q1) Prescribing patterns of antidepressants in europe: results from the factors influencing depression endpoints research (Finder) Bauer M, Monz BU, Montejo AL, Quail D, Dantchev N, Demyttenaere K, Garcia-Cebrian A, Grassi L, Perahia DG, Reed C, Tylee A. Study European Psychiatry 23(1):66-73. FI: 3.080 (Q2) Factors influencing depression endpoints research (finder): study design and population characteristics Garcia-Cebrian A, Bauer M, Montejo Al, Dantchev N, Demyttenaere K, Gandhi P, Grassi L, Monz BU, Perahia DG, Quail D, Tylee A. European Psychiatry2008. FI: 3.080 (Q2) `Caseness¿ for depression and anxiety in a depressed outpatient population (FINDER). Symptomatic outcome as a function of baseline diagnostic categories. Prim Care Companion Demyttenaere K, Verhaeghen A, Dantchev N, Grassi L, Montejo AL, Monz B, Perahia D, Quail D, Reed C, Tylee A, Bauer M. Journal of Clinical Psychiatry 11(6): 307¿315. FI: 5.218 (Q1) The socioeconomic costs of mental illness in Spain Moreno O, López-Bastida J, Montejo AL, Osuna R, Duque B. Journal of Health Economics 10:361¿369. FI: 1.885 (Q2)
|
